Your AAV production: Ready for take off​

aem-GridColumn aem-GridColumn--default--12

Aaviator

<h2>The AAViator™ Production Platform: Proven, out-of-the-box performance to accelerate your AAV manufacturing</h2>
<p>The AAViator™ Production Platform combines an integrated transfection system with chemically defined cell culture media to support efficient, scalable AAV vector manufacturing. Designed for maximum performance withless optimization, it helps improve productivity, streamline process development, and accelerate speed to clinic.​ This whitepaper shares practical insights and benchmark data to help manufacturers optimize upstream performance and support successful scale-up.​</p>
<p>What you'll discover:​</p>
<ul>
<li>Out-of-the-box productivity with high AAV titers and full capsid percentages​</li>
<li>A platform approach supporting process development and scale-up for accelerated speed to clinic​</li>
<li>Benchmark data demonstrating AAV performance across multiple serotypes, HEK293 cell lines, genes of interest, and manufacturing scales​</li>
<li>Factors influencing viral yield, consistency, and full capsid percentages​</li>
<li>Key considerations for reducing complexity throughout development and commercialization​</li>
</ul>


aem-GridColumn aem-GridColumn--default--8 aem-GridColumn--offset--default--0 aem-GridColumn--default--none

Interested in boosting AAV titers and capsid quality? Read our white paper on Streamlining your process with the AAViator™ Production Platform!

Your AAV production: Ready for take off​

The AAViator™ Production Platform: Proven, out-of-the-box performance to accelerate your AAV manufacturing

Your AAV production: Ready for take off